世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
18期
23-23
,共1页
热疗%放疗%化疗%宫颈癌%预后
熱療%放療%化療%宮頸癌%預後
열료%방료%화료%궁경암%예후
hyperthermia%radiotherapy%chemotherapy cervical carcinoma%prognosis
目的：研究热疗联合同步放化疗治疗41例宫颈癌的远期生存及预后因素。方法：41宫颈癌患者例均行根治性放疗，放疗的同时加化疗，热疗每次于放疗结束后2小时内进行，统计1年、3年生存率，用COX比例危险回归模型进行预后因素分析。结果：1年、3年生存率分别为：97.56%、78.05%，肿瘤病理、肿瘤分期是影响预后的主体因素。结论：热疗结合同步放化疗治疗宫颈癌疗效显著，可以提高宫颈癌的3年远期生存率；肿瘤病理、肿瘤分期是影响预后的主体因素。
目的：研究熱療聯閤同步放化療治療41例宮頸癌的遠期生存及預後因素。方法：41宮頸癌患者例均行根治性放療，放療的同時加化療，熱療每次于放療結束後2小時內進行，統計1年、3年生存率，用COX比例危險迴歸模型進行預後因素分析。結果：1年、3年生存率分彆為：97.56%、78.05%，腫瘤病理、腫瘤分期是影響預後的主體因素。結論：熱療結閤同步放化療治療宮頸癌療效顯著，可以提高宮頸癌的3年遠期生存率；腫瘤病理、腫瘤分期是影響預後的主體因素。
목적：연구열료연합동보방화료치료41례궁경암적원기생존급예후인소。방법：41궁경암환자례균행근치성방료，방료적동시가화료，열료매차우방료결속후2소시내진행，통계1년、3년생존솔，용COX비례위험회귀모형진행예후인소분석。결과：1년、3년생존솔분별위：97.56%、78.05%，종류병리、종류분기시영향예후적주체인소。결론：열료결합동보방화료치료궁경암료효현저，가이제고궁경암적3년원기생존솔；종류병리、종류분기시영향예후적주체인소。
Objective: To investigate the long-term survival rates and prognostic factors of the 41 cases patients with cervical carcinoma treated by hyperthermia combined with radiotherapy concurrently combined with chemotherapy. Methods: The 41cases were received radical radiotherapy combined with chemotherapy concurrently, hyperthermia was performed within 2 hours after radiotherapy every time, 1-year、3-year survival rates were counted, the COX proportional hazards model was used to analyze the prognostic factors. Results: 1-year、3-year survival rates were respectively 97.56% (40/41)、78.05%(32/41) , tumor pathology、tumor staging were the key factors in clinical prognosis. Conclusions: Effect of hyperthermia com-bined with radiotherapy concurrently combined with chemotherapy is distinct for the cervical carcinoma, which can improve the 3-year survival rates of cervical carcinoma, tumor pathology、tumor staging are the key factors in clinical prognosis.
